Sig Kirk Joins Assertio Board of Directors
03 April 2024 - 11:00PM
Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq:
ASRT), a pharmaceutical company with comprehensive commercial
capabilities offering differentiated products to patients, today
announced effectiveness of the appointment of Sigurd (Sig) Kirk to
its board of directors. He will serve on the Audit and Compensation
committees.
Kirk is a senior corporate business development executive with
more than 20 years of pharmaceutical experience in the areas of
branded biopharmaceutical, medical device and generic products. His
previous experience includes 11 years at Allergan plc, which was
acquired by AbbVie, Inc., as Executive Vice President, Corporate
Business Development, where he led more than 75 deals. Prior to
that, he served in multiple senior leadership roles at Barr
Pharmaceuticals, now Teva Pharmaceuticals, Inc., including Global
Controller and Chief Accounting Officer. Mr. Kirk started his
career at Deloitte & Touche as an Audit Manager, earning his
CPA certification. He holds a Bachelor of Business Administration
degree from Pace University.
“Sig’s extensive strategic business development, financial
management and diligence background are an excellent resource for a
growth-oriented business like Assertio as we continue to seek
exciting commercial assets where our innovative digital
non-personal promotion platform and efficient oncology field sales
force can deliver incremental performance,” said Heather Mason,
interim Chief Executive Officer. “Both Sig’s appointment and the
addition of Sravan Emany last fall demonstrate our ongoing
commitment to aligning our board expertise with our evolving
business strategies.”
About Assertio
Assertio is a commercial pharmaceutical company offering
differentiated products to patients. We have built our commercial
portfolio through acquisition or licensing of approved products.
Our comprehensive commercial capabilities include marketing through
both a sales force and a non-personal promotion model, market
access through payor contracting, and trade and distribution. To
learn more about Assertio, visit www.assertiotx.com.
Forward Looking Statements
Statements in this communication that are not historical facts
are forward-looking statements that reflect Assertio’s current
expectations, assumptions and estimates of future performance and
economic conditions. These forward-looking statements are made in
reliance on the safe harbor provisions of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. These forward-looking
statements relate to, among other things, future events or the
future performance or operations of Assertio, including risks
related to our ability to realize the benefits from our operating
model, successfully integrate new assets, explore new business
development initiatives, and successfully recruit a successor CEO
on a timely basis. All statements other than historical facts may
be forward-looking statements and can be identified by words such
as “anticipate,” “believe,” “could,” “design,” “estimate,”
“expect,” “forecast,” “goal,” “guidance,” “imply,” “intend,” “may,”
“objective,” “opportunity,” “outlook,” “plan,” “position,”
“potential,” “predict,” “project,” “prospective,” “pursue,” “seek,”
“should,” “strategy,” “target,” “would,” “will,” “aim” or other
similar expressions that convey the uncertainty of future events or
outcomes and are used to identify forward-looking statements. Such
forward-looking statements are not guarantees of future performance
and are subject to risks, uncertainties and other factors, some of
which are beyond the control of Assertio, including the risks
described in Assertio’s Annual Report on Form 10-K and Quarterly
Reports on Form 10-Q filed with the U.S. Securities and Exchange
Commission (“SEC”) and in other filings Assertio makes with the SEC
from time to time. Investors and potential investors are urged not
to place undue reliance on forward-looking statements in this
communication, which speak only as of this date. While Assertio may
elect to update these forward-looking statements at some point in
the future, it specifically disclaims any obligation to update or
revise any forward-looking-statements contained in this press
release whether as a result of new information or future events,
except as may be required by applicable law.
Investor Contact
Matt Kreps, Managing DirectorDarrow AssociatesM:
214-597-8200mkreps@darrowir.com
Assertio (NASDAQ:ASRT)
Historical Stock Chart
From Apr 2024 to May 2024
Assertio (NASDAQ:ASRT)
Historical Stock Chart
From May 2023 to May 2024